Kelly Malcom
Lead Research Communicator
Malcom is a lead research communicator for Michigan Medicine and research communications strategist for the U-M Medical School, with more than 20 years of experience in strategic communications, marketing, and health and science writing. She covers the basic science departments, pulmonary and critical care medicine, infectious disease, pathology and anesthesiology. Contact: [email protected]
News Release
New $13.8M center at U-M will study infectious disease, pandemic preparedness
As researchers around the world continue to combat the COVID-19 pandemic, most agree on one issue: If history is any indication, there's another pandemic coming.
News Release
U-M Pharmacology Chair Lori Isom elected to the National Academy of Medicine
Lori Isom, Ph.D., has been elected to the prestigious National Academy of Medicine, one of the highest honors for a clinician and scientist.
Health Lab
Patients’ referral to primary care after COVID-19 hospitalization varied widely during the pandemic
COVID-19 is currently a leading cause of sepsis in the United States, spurring experts to publish new guidance regarding primary care follow up for sepsis after hospitalization.
Health Lab
Study identifies sulfatase, a potential drug target for inflammatory bowel disease and colorectal cancer
Enzyme is behind the breakdown of the protective mucus barrier in the gut
Health Lab
Stem cells and their role in lung transplant rejection
New study reveals the location and behavior of specific cells behind lung fibrosis.
Health Lab
Should you get a booster dose of COVID vaccine?
Do you need a COVID vaccine booster shot? Follow this quick, easy-to-understand guide to the latest recommendations from the FDA and CDC for COVID vaccine booster doses.
Health Lab
Movement of genes within cells helps organisms tell time
A study in fruit flies reveals the dance of key proteins behind circadian rhythms.
Health Lab
Delirium is a common consequence of severe COVID-19, study finds
Cognitive impairment is highly likely for patients in the ICU and could be lasting.
Health Lab
Why Do People with Diabetes Develop Severe COVID-19?
Type 2 diabetes is one of the main risk factors for developing severe COVID-19 due to too much inflammation, often called a cytokine storm. New research shows a potential new therapy for these patients.
Health Lab
Low levels of electrical current can block pain
The method could be an alternative to opioids and other medication.
Health Lab
Existing drugs kill SARS-CoV-2 in cells
Could the next therapy for COVID-19 already be at your local pharmacy?
Health Lab
Short hospitalizations hit hard for COVID patients
Study hints at long-term health and financial impacts.
Health Lab
Masks and the delta variant
Do masks work against the delta variant? If you’re vaccinated, do you need to wear a mask? As the COVID pandemic continues, CDC mask wearing guidance adapts to current conditions.
News Release
New study aims to prioritize the patient recovery experience when determining anesthetic options
More than 50,000 surgical patients receive anesthetic care in the U.S. each day. But when it comes to deciding between two anesthetic medications that have been in use for decades, clinicians and patients have little scientific evidence to compare effectiveness and risks.
Health Lab
What the Delta variant means for COVID-19 spread and vaccines
The Delta variant of COVID-19 is more transmissible and can cause breakthrough infections even in vaccinated people, but what does it mean practically for the vaccinated and unvaccinated, the immunocompromised and kids?
